Detalhe da pesquisa
1.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139274
2.
Analysis of simplicial complexes to determine when to sample for quantitative DCE MRI of the breast.
Magn Reson Med
; 89(3): 1134-1150, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321574
3.
Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting.
Breast Cancer Res
; 23(1): 110, 2021 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838096
4.
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
Breast Cancer Res Treat
; 184(1): 161-172, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789591
5.
Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.
Support Care Cancer
; 28(2): 925-932, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172284
6.
Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting.
J Magn Reson Imaging
; 2018 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570895
7.
Use of Tokens to Unlock Greater Data Sharing in Health Care.
JAMA
; 330(24): 2333-2334, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983066
8.
The treatment patterns, efficacy, and safety of nab (®)-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis.
BMC Cancer
; 15: 1019, 2015 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26714468
9.
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
J Natl Compr Canc Netw
; 13(11): 1383-93, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553767
10.
Iniparib plus chemotherapy in metastatic triple-negative breast cancer.
N Engl J Med
; 364(3): 205-14, 2011 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21208101
11.
Telemedicine and Burnout-How Enhancing Operational Support Can Improve Digital Health Tools.
Cancer J
; 30(1): 31-33, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265924
12.
Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting.
Oncologist
; 18(6): 760-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23650020
13.
Debra Patt on How the Management of Cancer is Changing as Patients Live Longer.
Oncology (Williston Park)
; 32(6): 274-5, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29940056
14.
Cancer Informatics 2023: Data Sharing and Federating Learning Point Towards New Collaborative Opportunities.
Yearb Med Inform
; 32(1): 111-114, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147854
15.
Tenets for Implementing Electronic Patient-Reported Outcomes for Remote Symptom Monitoring During Cancer Treatment.
JCO Clin Cancer Inform
; 7: e2200187, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36857630
16.
Patient-Reported Outcomes, Digital Health, and the Quest to Improve Health Equity.
Am Soc Clin Oncol Educ Book
; 43: e390678, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290027
17.
Impact of Remote Symptom Monitoring With Electronic Patient-Reported Outcomes on Hospitalization, Survival, and Cost in Community Oncology Practice: The Texas Two-Step Study.
JCO Clin Cancer Inform
; 7: e2300182, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897263
18.
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Eur J Cancer
; 184: 48-59, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898233
19.
Cancer Informatics 2022: Real-World Data Yields Important Insights into the Conduct of Clinical Trials and Registries.
Yearb Med Inform
; 31(1): 131-134, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463870
20.
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.
Clin Breast Cancer
; 22(6): 601-610, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643624